The Study of CM326 in Moderate-to-severe Atopic Dermatitis

NCT05671432 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Atopic Dermatitis

Interventions

BIOLOGICAL: CM326
OTHER: Placebo

Sponsor

Keymed Biosciences Co.Ltd